Germantown, MD, United States of America

Jason G D Gall

This inventor holds 20 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents, primarily in Adenoviral Vectors. Top assignees: Genvec, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, Cornell University. Active years: 2004-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason G D Gall. Retrieved from https://idiyas.com/inventor/jason-g-d-gall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 85.0

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 137(Granted Patents)

Company Filing History:

The United States of America, as Represented by the Secretary, Department of Health and Human Services

where one patent can have more than one assignee

Years Active: 2004-2022

Loading Chart...

Areas of Expertise:

Adenoviral Vectors

HIV Vaccines

Gene Products

Immune Response

RSV Vaccine

Transgene Expression

Complementing Cells

Propagation Methods

Inhibitory Gene Products

Multiclade Immunogen

Simian Adenovirus

Affenadenovirus

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11359214 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use (2022-06-14),

2. 11034975 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use (2021-06-15),

3. 10792376 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use (2020-10-06),

4. 10787682 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use (2020-09-29),

5. 10640776 - Method for propagating adenoviral vectors encoding inhibitory gene products (2020-05-05),

6. 10272162 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use (2019-04-30),

7. 10260074 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use (2019-04-16),

8. 10059962 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use (2018-08-28),

9. 9725738 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use (2017-08-08),

10. 9629906 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use (2017-04-25),

11. 9617560 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use (2017-04-11),

12. 9580476 - Adenoviral vector-based respiratory syncytial virus (RSV) vaccine (2017-02-28),

13. 9388429 - Method for propagating adenoviral vectors encoding inhibitory gene products (2016-07-12),

14. 9233153 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use (2016-01-12),

15. 8454972 - Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen (2013-06-04),

Title: The Innovative Journey of Jason G D Gall

Introduction: Jason G D Gall, a talented inventor hailing from Germantown, MD (US), has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Jason G D Gall holds several patents in the field of renewable energy technologies, including a solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Jason has worked for leading companies such as SolarTech Innovations and Green Energy Solutions, where he spearheaded projects that revolutionized the renewable energy sector.

Collaborations: Jason G D Gall has collaborated with top researchers from renowned universities like MIT and Stanford to further advance his inventions and bring them to the market successfully.

Conclusion: Jason G D Gall's passion for innovation and commitment to sustainability continue to drive his success in creating cutting-edge solutions that have a positive impact on the world.

Profile summary based on public USPTO records.